Laigle-Donadey, F. et al. Dural metastases. J. Neurooncol. 75, 57–61 (2005).
Nayak, L. et al. Intracranial dural metastases. Cancer 115, 1947–1953 (2009).
Ahn, S. J. et al. Dural metastasis in breast cancer: MRI-based morphological subtypes and their clinical implications. Cancer Res. Treat. 56, 1105–1112 (2024).
Rodriguez-Calero, A. et al. Alterations in homologous recombination repair genes in prostate cancer brain metastases. Nat. Commun. 13, 2400 (2022).
Nassiri, F. et al. A clinically applicable integrative molecular classification of meningiomas. Nature 597, 119–125 (2021).
Wang, A. Z. et al. Single-cell profiling of human dura and meningioma reveals cellular meningeal landscape and insights into meningioma immune response. Genome Med. 14, 49 (2022).
Rippaus, N. et al. Metastatic site-specific polarization of macrophages in intracranial breast cancer metastases. Oncotarget 7, 41473–41487 (2016).
Merlini, A. et al. Distinct roles of the meningeal layers in CNS autoimmunity. Nat. Neurosci. 25, 887–899 (2022).
Koh, B. I. et al. Adult skull bone marrow is an expanding and resilient haematopoietic reservoir. Nature 636, 172–181 (2024).
Kolabas, Z. I. et al. Distinct molecular profiles of skull bone marrow in health and neurological disorders. Cell 186, 3706–3725 (2023).
Dobersalske, C. et al. Cranioencephalic functional lymphoid units in glioblastoma. Nat. Med. 30, 2947–2956 (2024).
Lad, M. et al. Glioblastoma induces the recruitment and differentiation of dendritic-like ‘hybrid’ neutrophils from skull bone marrow. Cancer Cell 42, 1549–1569 (2024).
Rustenhoven, J. et al. Functional characterization of the dural sinuses as a neuroimmune interface. Cell 184, 1000–1016 (2021).
Herisson, F. et al. Direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration. Nat. Neurosci. 21, 1209–1217 (2018).
Pulous, F. E. et al. Cerebrospinal fluid can exit into the skull bone marrow and instruct cranial hematopoiesis in mice with bacterial meningitis. Nat. Neurosci. 25, 567–576 (2022).
Louveau, A. et al. Structural and functional features of central nervous system lymphatic vessels. Nature 523, 337–341 (2015).
Aspelund, A. et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J. Exp. Med. 212, 991–999 (2015).
Zhao, J. et al. Dura immunity configures leptomeningeal metastasis immunosuppression for cerebrospinal fluid barrier invasion. Nat. Cancer 5, 1940–1961 (2024).
Sankowski, R. et al. Multiomic spatial landscape of innate immune cells at human central nervous system borders. Nat. Med. 30, 186–198 (2024).
Hu, X. et al. Meningeal lymphatic vessels regulate brain tumor drainage and immunity. Cell Res. 30, 229–243 (2020).
Song, E. et al. VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours. Nature 577, 689–694 (2020).
Zhou, C. et al. Meningeal lymphatics regulate radiotherapy efficacy through modulating anti-tumor immunity. Cell Res. 32, 543–554 (2022).
Salvador, A. F. M. et al. Meningeal lymphatics in central nervous system diseases. Annu. Rev. Neurosci. 47, 323–344 (2024).
Dissing-Olesen, L. et al. New brain lymphatic vessels drain old concepts. eBioMedicine 2, 776–777 (2015).
Petrova, T. V. et al. Biological functions of lymphatic vessels. Science 369, eaax4063 (2020).
Janardhan, H. P. et al. Lymphatic system in organ development, function, and regeneration. Circ. Res. 132, 1181–1184 (2023).
Louveau, A. et al. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat. Neurosci. 21, 1380–1391 (2018).
Alves de Lima, K. et al. Meningeal immunity and its function in maintenance of the central nervous system in health and disease. Annu. Rev. Immunol. 38, 597–620 (2020).
Graham, M. S. et al. Meningeal lymphatics prime tumor immunity in glioblastoma. Cancer Cell 39, 304–306 (2021).
Kovacs, M. A. et al. Meningeal lymphatic drainage promotes T cell responses against Toxoplasma gondii but is dispensable for parasite control in the brain. eLife 11, e80775 (2022).
Castellani, G. et al. Transforming the understanding of brain immunity. Science 380, eabo7649 (2023).
Oliveira, G. et al. Dynamics and specificities of T cells in cancer immunotherapy. Nat. Rev. Cancer 23, 295–316 (2023).
John, L. et al. Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level. Nat. Commun. 14, 5011 (2023).
Monroy, M. et al. Lymphatics in bone arise from pre-existing lymphatics. Development 147, dev184291 (2020).
Zhang, D. et al. Reduced expression of semaphorin 3A in osteoclasts causes lymphatic expansion in a Gorham–Stout disease (GSD) mouse model. J. Zhejiang Univ. Sci. B 25, 38–50 (2024).
Wang, W. et al. Lymphatic endothelial cells produce M-CSF, causing massive bone loss in mice. J. Bone Miner. Res. 32, 939–950 (2017).
Sato, K. et al. RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer. Am. J. Pathol. 182, 1890–1899 (2013).
Renema, N. et al. RANK–RANKL signalling in cancer. Biosci. Rep. 36, e00366 (2016).
Li, E. C. et al. Zoledronic acid: a new parenteral bisphosphonate. Clin. Ther. 25, 2669–2708 (2003).
Russell, R. G. Bisphosphonates: the first 40 years. Bone 49, 2–19 (2011).
Wang, L. et al. Mechanical sensing protein PIEZO1 regulates bone homeostasis via osteoblast-osteoclast crosstalk. Nat. Commun. 11, 282 (2020).
Nakamura, T. et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130, 811–823 (2007).
Yang, W. et al. Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling. Nature 499, 491–495 (2013).
Feng, H. et al. Tendon-derived cathepsin K-expressing progenitor cells activate Hedgehog signaling to drive heterotopic ossification. J. Clin. Invest. 130, 6354–6365 (2020).
Debnath, S. et al. Discovery of a periosteal stem cell mediating intramembranous bone formation. Nature 562, 133–139 (2018).
Han, Y. et al. Lkb1 deletion in periosteal mesenchymal progenitors induces osteogenic tumors through mTORC1 activation. J. Clin. Invest. 129, 1895–1909 (2019).
McDonald, M. M. et al. Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption. Cell 184, 1330–1347 (2021).
Tsukasaki, M. et al. Stepwise cell fate decision pathways during osteoclastogenesis at single-cell resolution. Nat. Metab. 2, 1382–1390 (2020).
Dieterich, L. C. et al. Lymphatic vessels in cancer. Physiol. Rev. 102, 1837–1879 (2022).
Zheng, W. et al. Lymphangiogenic factors, mechanisms, and applications. J. Clin. Invest. 124, 878–887 (2014).
Souma, T. et al. Context-dependent functions of angiopoietin 2 are determined by the endothelial phosphatase VEPTP. Proc. Natl Acad. Sci. USA 115, 1298–1303 (2018).
Khosraviani, N. et al. Angiopoietin-2: an emerging tie to pathological vessel enlargement. Arterioscler. Thromb. Vasc. Biol. 42, 3–5 (2022).
Lu, X. et al. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. Cancer Cell 20, 701–714 (2011).
Sethi, N. et al. Tumor-derived Jagged1 promotes osteolytic bone metastasis of breast cancer by engaging Notch signaling in bone cells. Cancer Cell 19, 192–205 (2011).
Hirbe, A. C. et al. Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner. Blood 109, 3424–3431 (2006).
Yue, Z. et al. RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis. J. Clin. Invest. 132, e144579 (2022).
Cheng, J.-N. et al. Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclasts. Cancer Cell 43, 1093–1107 (2025).
Hua, X. Y. et al. Structural and functional characteristics of leptomeningeal lymphatic vessels in leptomeningeal metastases from lung cancer patients. Preprint at Research Square https://doi.org/10.21203/rs.3.rs-5244229/v1 (2024).
Schulz, P. et al. Angiopoietin-2 drives lymphatic metastasis of pancreatic cancer. FASEB J. 25, 3325–3335 (2011).
Fagiani, E. et al. Angiopoietin-1 and -2 exert antagonistic functions in tumor angiogenesis, yet both induce lymphangiogenesis. Cancer Res. 71, 5717–5727 (2011).
Chi, Y. et al. Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis. Science 369, 276–282 (2020).
Boire, A. et al. Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis. Cell 168, 1101–1113 (2017).
Choi, D. et al. Piezo1 regulates meningeal lymphatic vessel drainage and alleviates excessive CSF accumulation. Nat. Neurosci. 27, 913–926 (2024).
Butler, A. et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411–420 (2018).
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
Gu, Z. et al. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847–2849 (2016).
Yu, G. et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284–287 (2012).